[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
Murakawa
Y
Y
Tsutsumi
M
M
Murata
N
N
Sasaki
Y
Y
Tsujiuchi
T
T
Mikasa
K
K
Narita
N
N
Konishi
Y
Y
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000139:chemically induced / Q000517:prevention & control*; D002908:Chronic Disease; D017291:Clarithromycin / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D017308:Etodolac / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D009602:Nitrosamines; D011014:Pneumonia / Q000139:chemically induced / Q000517:prevention & control; D051381:Rats; D017208:Rats, Wistar
D000900:Anti-Bacterial Agents; D016861:Cyclooxygenase Inhibitors; D009602:Nitrosamines; D017308:Etodolac; C012457:diisopropanolnitrosamine; D017291:Clarithromycin